SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021043
Filing Date
2018-08-09
Accepted
2018-08-09 16:09:30
Documents
44
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20180630.htm 10-Q 951807
2 EX-31.1 evok-ex311_7.htm EX-31.1 9585
3 EX-31.2 evok-ex312_10.htm EX-31.2 9869
4 EX-32.1 evok-ex321_6.htm EX-32.1 5026
5 EX-32.2 evok-ex322_9.htm EX-32.2 5255
  Complete submission text file 0001564590-18-021043.txt   3908478

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20180630.xml EX-101.INS 930307
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20180630.xsd EX-101.SCH 32654
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20180630_cal.xml EX-101.CAL 18984
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20180630_def.xml EX-101.DEF 99581
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20180630_lab.xml EX-101.LAB 223720
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20180630_pre.xml EX-101.PRE 168302
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 181005101
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences